Vicarious Surgical (RBOT) Other Working Capital Changes (2023 - 2025)
Vicarious Surgical's (RBOT) quarterly Other Working Capital Changes came in at -$312000.0 in Q3 2025, down 15.99% year-on-year from -$371362.8 in Q3 2024, and down 1.96% on a QoQ basis from -$306000.0 in Q2 2025.
Vicarious Surgical (RBOT) Other Working Capital Changes (2023 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has 4 years of Other Working Capital Changes data on file, last reported at -$312000.0 in Q3 2025.
- On a quarterly basis, Other Working Capital Changes fell 15.99% year-over-year to -$312000.0 in Q3 2025; TTM through Sep 2025 was -$1.2 million, a 16.58% decrease from a year earlier, with the FY2024 full-year figure at -$1.0 million, down 24.94% from the prior year.
- Other Working Capital Changes for Q3 2025 stood at -$312000.0, down from -$306000.0 in the prior quarter.
- Over the last five years, Other Working Capital Changes for RBOT reached as high as $724000.0 in Q3 2023 and fell as low as -$1.1 million in Q2 2023.
- Historically, Other Working Capital Changes has averaged -$230454.5 across 3 years, with a median of -$311000.0 in 2025.
- Across the five-year window, Other Working Capital Changes tumbled 189.82% in 2023 and retreated 15.99% in 2025, its largest moves.
- Year by year, Other Working Capital Changes stood at -$146000.0 in 2022, then tumbled by 60.96% to -$235000.0 in 2023, then declined by 17.02% to -$275000.0 in 2024, then dropped by 13.45% to -$312000.0 in 2025.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$312000.0 in Q3 2025, -$306000.0 in Q2 2025, and -$281000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.32 Bn | 177.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn |
| 3 | Medtronic | 108.88 Bn | 99.66 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.65 Bn | 67.20 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.43 Bn | 43.76 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.48 Bn | 26.19 Bn | 1.98 Bn |
| 7 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.98 Bn | 26.40 Bn | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn |
| 10 | Vicarious Surgical | 625,212.51 | -9.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -443,000.00 |
| Sep 30, 2025 | -443,000.00 |
| Sep 30, 2025 | -443,000.00 |
| Jun 30, 2025 | -186,000.00 |
| Jun 30, 2025 | -186,000.00 |
| Jun 30, 2025 | -186,000.00 |
| Mar 31, 2025 | -311,000.00 |
| Mar 31, 2025 | -311,000.00 |
| Mar 31, 2025 | -311,000.00 |
| Dec 31, 2024 | 509,000.00 |
| Dec 31, 2024 | 509,000.00 |
| Dec 31, 2024 | 509,000.00 |
| Sep 30, 2024 | -611,000.00 |
| Sep 30, 2024 | -611,000.00 |
| Sep 30, 2024 | -611,000.00 |
| Jun 30, 2024 | -282,000.00 |
| Jun 30, 2024 | -282,000.00 |
| Jun 30, 2024 | -282,000.00 |
| Mar 31, 2024 | 209,000.00 |
| Mar 31, 2024 | 209,000.00 |